N/A
N=32
An Innovative Taping Technique for Improved Intravenous (IV) Catheter Securement
Dislodged Catheter · Catheter Related Complication
Bottom Line
View on ClinicalTrials.gov: NCT05948878 ↗Enrolled (actual)
32
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: The Force (Newtons) Required to Dislodge an IV Catheter Secured in the Retrograde Direction. — 28.65; 15.41; 19.29 Newtons
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Novel Taping Method (Device); BCH Emergency Department Taping Method (Device); Chevron Taping Method (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Boston Children's Hospital
- Primary completion
- Nov 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Force (Newtons) Required to Dislodge an IV Catheter Secured in the Retrograde Direction. |
28.65; 15.41; 19.29 | — |
| PRIMARY The Force (Newtons) Required to Dislodge an IV Catheter Secured in a 90 Degrees Direction. |
20.85; 13.68; 13.16 | — |
Summary
This is a prospective, single-blinded, randomized study to assess the ability of taping methods used to secure intravenous (IV) catheters to resist the IV from being pulled away from the skin. Participants will have IV catheters taped on top of the skin (without insertion into the skin) using three taping methods, BCH Emergency Department (BCH ED), Chevron, and our novel method. Six measurements will be obtained per subject (3 random taping methods measuring their resistance to force in two directions, retrograde direction or towards the wrist and 90-degree angle to the arm).
Eligibility Criteria
Inclusion Criteria
- Employees of Boston Children's Hospital
Exclusion Criteria
- Individuals under the direct supervision of any study investigators
- Individuals with excessive hair in/near the antecubital fossa region on either arm
- Individuals with fragile and/or non-intact skin in/near the antecubital fossa region
- Individuals who have adhesive allergies
- Individuals who have already participated
Data sourced from ClinicalTrials.gov (NCT05948878). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.